These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31581411)

  • 1. Radiosurgery and Immunotherapy in the Treatment of Brain Metastases.
    Ramakrishna R; Formenti S
    World Neurosurg; 2019 Oct; 130():615-622. PubMed ID: 31581411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal Timing and Sequence of Immunotherapy When Combined with Stereotactic Radiosurgery in the Treatment of Brain Metastases.
    ElJalby M; Pannullo SC; Schwartz TH; Parashar B; Wernicke AG
    World Neurosurg; 2019 Jul; 127():397-404. PubMed ID: 31004856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
    Chen L; Douglass J; Kleinberg L; Ye X; Marciscano AE; Forde PM; Brahmer J; Lipson E; Sharfman W; Hammers H; Naidoo J; Bettegowda C; Lim M; Redmond KJ
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):916-925. PubMed ID: 29485071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent versus non-concurrent immune checkpoint inhibition with stereotactic radiosurgery for metastatic brain disease: a systematic review and meta-analysis.
    Lu VM; Goyal A; Rovin RA; Lee A; McDonald KL
    J Neurooncol; 2019 Jan; 141(1):1-12. PubMed ID: 30392086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery.
    Qian JM; Yu JB; Kluger HM; Chiang VL
    Cancer; 2016 Oct; 122(19):3051-8. PubMed ID: 27285122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic radiosurgery combined with immune checkpoint inhibitors or kinase inhibitors for patients with multiple brain metastases of malignant melanoma.
    Stera S; Balermpas P; Blanck O; Wolff R; Wurster S; Baumann R; Szücs M; Loutfi-Krauss B; Wilhelm ML; Seifert V; Rades D; Rödel C; Dunst J; Hildebrandt G; Arnold A; Meissner M; Kähler KC
    Melanoma Res; 2019 Apr; 29(2):187-195. PubMed ID: 30802230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic radiosurgery and immunotherapy in melanoma brain metastases: Patterns of care and treatment outcomes.
    Gabani P; Fischer-Valuck BW; Johanns TM; Hernandez-Aya LF; Keller JW; Rich KM; Kim AH; Dunn GP; Robinson CG; Chicoine MR; Huang J; Abraham CD
    Radiother Oncol; 2018 Aug; 128(2):266-273. PubMed ID: 29960685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy Plus Stereotactic Radiosurgery: Building on the Promise of Precision Medicine for CNS Malignancies-PART 1: Principles of Combined Treatment.
    Zhang I; Formenti SC; Knisely JPS
    Oncology (Williston Park); 2018 Feb; 32(2):e28-e32. PubMed ID: 29492951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Brain Metastases in the New Era of Checkpoint Inhibition.
    Lauko A; Thapa B; Venur VA; Ahluwalia MS
    Curr Neurol Neurosci Rep; 2018 Aug; 18(10):70. PubMed ID: 30121715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy and immunotherapy: Can this combination change the prognosis of patients with melanoma brain metastases?
    Franceschini D; Franzese C; Navarria P; Ascolese AM; De Rose F; Del Vecchio M; Santoro A; Scorsetti M
    Cancer Treat Rev; 2016 Nov; 50():1-8. PubMed ID: 27566962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy Plus Stereotactic Radiosurgery: Building on the Promise of Precision Medicine for CNS Malignancies-PART 2: Existing Experience and Considerations for Future Trials.
    Zhang I; Formenti SC; Knisely JPS
    Oncology (Williston Park); 2018 Mar; 32(3):e33-e37. PubMed ID: 29548066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
    Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
    J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma brain metastasis: the impact of stereotactic radiosurgery, BRAF mutational status, and targeted and/or immune-based therapies on treatment outcome.
    Kotecha R; Miller JA; Venur VA; Mohammadi AM; Chao ST; Suh JH; Barnett GH; Murphy ES; Funchain P; Yu JS; Vogelbaum MA; Angelov L; Ahluwalia MS
    J Neurosurg; 2018 Jul; 129(1):50-59. PubMed ID: 28799876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic therapy for brain metastases.
    Venur VA; Karivedu V; Ahluwalia MS
    Handb Clin Neurol; 2018; 149():137-153. PubMed ID: 29307351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of survival rates for treatment of melanoma metastatic to the brain.
    Stone A; Cooper J; Koenig KL; Golfinos JG; Oratz R
    Cancer Invest; 2004; 22(4):492-7. PubMed ID: 15565805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined irradiation and targeted therapy or immune checkpoint blockade in brain metastases: toxicities and efficacy.
    Tallet AV; Dhermain F; Le Rhun E; Noël G; Kirova YM
    Ann Oncol; 2017 Dec; 28(12):2962-2976. PubMed ID: 29045524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of melanoma brain metastases with radiation and immunotherapy or targeted therapy: A systematic review with meta-analysis.
    Williams GJ; Hong AM; Thompson JF
    Crit Rev Oncol Hematol; 2024 Oct; 202():104462. PubMed ID: 39097248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of melanoma patients treated with targeted therapy and immunotherapy after systematic upfront control of brain metastases by radiosurgery.
    Gaudy-Marqueste C; Dussouil AS; Carron R; Troin L; Malissen N; Loundou A; Monestier S; Mallet S; Richard MA; Régis JM; Grob JJ
    Eur J Cancer; 2017 Oct; 84():44-54. PubMed ID: 28783540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of brain metastases with stereotactic radiosurgery and immune checkpoint inhibitors: An international meta-analysis of individual patient data.
    Lehrer EJ; Peterson J; Brown PD; Sheehan JP; Quiñones-Hinojosa A; Zaorsky NG; Trifiletti DM
    Radiother Oncol; 2019 Jan; 130():104-112. PubMed ID: 30241791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two heads better than one? Ipilimumab immunotherapy and radiation therapy for melanoma brain metastases.
    Patel KR; Lawson DH; Kudchadkar RR; Carthon BC; Oliver DE; Okwan-Duodu D; Ahmed R; Khan MK
    Neuro Oncol; 2015 Oct; 17(10):1312-21. PubMed ID: 26014049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.